Alpha-fetoprotein assessment for hepatocellular carcinoma after transarterial chemoembolization

被引:0
作者
Min Tian
Xiaoying Zhang
Guihua Huang
Wenzhe Fan
Jiaping Li
Yingqiang Zhang
机构
[1] The First Affiliated Hospital of Hunan Normal University,Department of Radiology, Hunan Provincial People’s Hospital
[2] Sun Yat-sen University,Health Management Center, The Seventh Affiliated Hospital
[3] Sun Yat-sen University,Digestive Disease Center, The Seventh Affiliated Hospital
[4] Sun Yat-sen University,Department of Interventional Oncology, The First Affiliated Hospital
[5] Sun Yat-sen University,Department of Interventional Radiology, The Seventh Affiliated Hospital
来源
Abdominal Radiology | 2019年 / 44卷
关键词
Alpha-fetoprotein; Transarterial chemoembolization; Hepatocellular carcinoma; Assessment; Radiology; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3304 / 3311
页数:7
相关论文
共 104 条
[11]  
Tso WK(2010)Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 52-60
[12]  
Omata M(2013)Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization J Hepatol 58 1181-1187
[13]  
Lesmana LA(2011)EASL and mRECIST response are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial chemoembolization J Hepatol 55 1309-1316
[14]  
Tateishi R(2012)Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models Radiology 262 708-718
[15]  
Llovet JM(1972)Serum alpha-fetoprotein as a biochemical marker for hepatocellular carcinoma Cancer Res 32 1941-1946
[16]  
Bruix J(2000)Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels J Clin Gastroenterol 31 302-308
[17]  
Miller AB(2009)Hepatocellular carcinoma (HCC) and diagnostic significance of alpha-fetoprotein (AFP) J Ayub Med Coll Abbottabad 21 72-75
[18]  
Hoogstraten B(2018)Comparison of alpha-fetoprotein criteria and mRECIST for the prediction of overall survival of hepatocellular carcinoma patients after transarterial chemoembolization J Vasc Interv Radiol 29 1654-1661
[19]  
Staquet M(2009)New utility of an old marker: serial alpha-fetoprotein measurement in prediting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy J Clin Oncol 27 446-452
[20]  
Therasse P(2012)Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma J Hepatol 57 101-107